{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:32:19Z","timestamp":1790638339920,"version":"4.1.0"},"reference-count":113,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CN"],"published-print":{"date-parts":[[2020,5,20]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Amyloid-&amp;#946; (A&amp;#946;) has long been shown to be critical in Alzheimer\u2019s disease pathophysiology.\nMicroglia contributes to the earliest responses to A&amp;#946; buildup, by direct interaction through\nmultiple receptors. Microglial cells operate A&amp;#946; clearance and trigger inflammatory\/regenerative\nprocesses that take place in the long years of silent disease progression that precede symptomatic\nappearance. But in time and with aging, the fine balance between pro- and anti-inflammatory activity\nof microglia deranges, negatively impacting its A&amp;#946;-clearing ability. Furthermore, in recent years,\nmicroglial activation has proven to be much more complex than the mere dichotomic pro\/antiinflammatory\npolarization previously accepted. Microglia can display a wide spectrum of phenotypes,\nwhich can even be mixed. On these bases, it is evident that while pharmacological intervention\naiding microglia to prolong its ability to cope with A\u03b2 buildup could be extremely relevant, its\nfeasibility is hampered by such high complexity, which still needs to be completely understood.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1570159x18666200131105418","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T14:09:17Z","timestamp":1580479757000},"page":"446-455","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["The Ambiguous Role of Microglia in A\u03b2 Toxicity: Chances for Therapeutic Intervention"],"prefix":"10.2174","volume":"18","author":[{"given":"Sara","family":"Merlo","sequence":"first","affiliation":[{"name":"Department of Biomedical and Biotechnological Sciences, Section of Pharmacology; University of Catania, Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona Federica","family":"Spampinato","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Biotechnological Sciences, Section of Pharmacology; University of Catania, Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia Ilaria","family":"Caruso","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Biotechnological Sciences, Section of Pharmacology; University of Catania, Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Angela","family":"Sortino","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Biotechnological Sciences, Section of Pharmacology; University of Catania, Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fnins.2018.00037","volume":"12","author":"Frozza R.L.","year":"2018","unstructured":"Frozza R.L.; Lourenco M.V.; De Felice F.G.; Challenges for Alzheimer\u2019s disease therapy: Insights from novel mechanisms beyond memory defects. Front Neurosci 2018,12,37","journal-title":"Front Neurosci"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.trci.2018.03.009","volume":"4","author":"Cummings J.","year":"2018","unstructured":"Cummings J.; Lee G.; Ritter A.; Zhong K.; Alzheimer\u2019s disease drug development pipeline: 2018. Alzheimers Dement (N Y) 2018,4,195-214","journal-title":"Alzheimers Dement (N Y)"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.neuron.2014.10.038","volume":"84","author":"Sperling R.","year":"2014","unstructured":"Sperling R.; Mormino E.; Johnson K.; The evolution of preclinical Alzheimer\u2019s disease: implications for prevention trials. Neuron 2014,84(3),608-622","journal-title":"Neuron"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/cns.13050","volume":"25","author":"Merlo S.","year":"2019","unstructured":"Merlo S.; Spampinato S.F.; Sortino M.A.; Early compensatory responses against neuronal injury: A new therapeutic window of opportunity for Alzheimer\u2019s Disease? CNS Neurosci Ther 2019,25(1),5-13","journal-title":"CNS Neurosci Ther"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"7297","DOI":"10.1038\/s41598-018-25453-1","volume":"8","author":"Merlo S.","year":"2018","unstructured":"Merlo S.; Spampinato S.F.; Beneventano M.; Sortino M.A.; The contribution of microglia to early synaptic compensatory responses that precede \u03b2-amyloid-induced neuronal death. Sci Rep 2018,8(1),7297","journal-title":"Sci Rep"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","volume":"164","author":"De Strooper B.","year":"2016","unstructured":"De Strooper B.; Karran E.; The cellular phase of Alzheimer\u2019s disease. Cell 2016,164(4),603-615","journal-title":"Cell"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s10571-017-0574-1","volume":"38","author":"Chong F.P.","year":"2018","unstructured":"Chong F.P.; Ng K.Y.; Koh R.Y.; Chye S.M.; Tau Proteins and Tauopathies in Alzheimer\u2019s Disease. Cell Mol Neurobiol 2018,38(5),965-980","journal-title":"Cell Mol Neurobiol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"Hardy J.","year":"2002","unstructured":"Hardy J.; Selkoe D.J.; The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 2002,297(5580),353-356","journal-title":"Science"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"S567","DOI":"10.3233\/JAD-179941","volume":"64","author":"Cline E.N.","year":"2018","unstructured":"Cline E.N.; Bicca M.A.; Viola K.L.; Klein W.L.; The amyloid-\u03b2 oligomer hypothesis: beginning of the third decade. J Alzheimers Dis 2018,64(s1),S567-S610","journal-title":"J Alzheimers Dis"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","volume":"4","author":"Kinney J.W.","year":"2018","unstructured":"Kinney J.W.; Bemiller S.M.; Murtishaw A.S.; Leisgang A.M.; Salazar A.M.; Lamb B.T.; Inflammation as a central mechanism in Alzheimer\u2019s disease. Alzheimers Dement (N Y) 2018,4,575-590","journal-title":"Alzheimers Dement (N Y)"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.3389\/fphar.2019.01024","volume":"10","author":"Caraci F.","year":"2019","unstructured":"Caraci F.; Merlo S.; Drago F.; Caruso G.; Parenti C.; Sortino M.A.; Rescue of noradrenergic system as a novel pharmacological strategy in the treatment of chronic pain: focus on microglia activation. Front Pharmacol 2019,10,1024","journal-title":"Front Pharmacol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3109\/00207454.2013.833510","volume":"124","author":"Cai Z.","year":"2014","unstructured":"Cai Z.; Hussain M.D.; Yan L.J.; Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer\u2019s disease. Int J Neurosci 2014,124(5),307-321","journal-title":"Int J Neurosci"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/imcb.12301","volume":"98","author":"Webers A.","year":"2020","unstructured":"Webers A.; Heneka M.T.; Gleeson P.A.; The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer\u2019s disease. Immunol Cell Biol 2020,98(1),28-41","journal-title":"Immunol Cell Biol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/jnc.13411","volume":"136","author":"Minter M.R.","year":"2016","unstructured":"Minter M.R.; Taylor J.M.; Crack P.J.; The contribution of neuroinflammation to amyloid toxicity in Alzheimer\u2019s disease. J Neurochem 2016,136(3),457-474","journal-title":"J Neurochem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"812","DOI":"10.3389\/fphar.2017.00812","volume":"8","author":"Beneventano M.","year":"2017","unstructured":"Beneventano M.; Spampinato S.F.; Merlo S.; Chisari M.; Platania P.; Ragusa M.; Purrello M.; Nicoletti F.; Sortino M.A.; Shedding of microvesicles from microglia contributes to the effects induced by metabotropic glutamate receptor 5 activation on neuronal death. Front Pharmacol 2017,8,812","journal-title":"Front Pharmacol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-3-030-05542-4_5","volume":"1118","author":"Takatori S.","year":"2019","unstructured":"Takatori S.; Wang W.; Iguchi A.; Tomita T.; Genetic risk factors for alzheimer disease: emerging roles of microglia in disease pathomechanisms. Adv Exp Med Biol 2019,1118,83-116","journal-title":"Adv Exp Med Biol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3389\/fphar.2019.00840","volume":"10","author":"Biber K.","year":"2019","unstructured":"Biber K.; Bhattacharya A.; Campbell B.M.; Piro J.R.; Rohe M.; Staal R.G.W.; Talanian R.V.; M\u00f6ller T.; Microglial drug targets in ad: opportunities and challenges in drug discovery and development. Front Pharmacol 2019,10,840","journal-title":"Front Pharmacol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1146\/annurev-physiol-022516-034406","volume":"79","author":"Wolf S.A.","year":"2017","unstructured":"Wolf S.A.; Boddeke H.W.; Kettenmann H.; Microglia in physiology and disease. Annu Rev Physiol 2017,79,619-643","journal-title":"Annu Rev Physiol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1742-2094-11-98","volume":"11","author":"Cherry J.D.","year":"2014","unstructured":"Cherry J.D.; Olschowka J.A.; O\u2019Banion M.K.; Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J Neuroinflammation 2014,11,98","journal-title":"J Neuroinflammation"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"7567","DOI":"10.1007\/s12035-016-0245-0","volume":"54","author":"Du L.","year":"2017","unstructured":"Du L.; Zhang Y.; Chen Y.; Zhu J.; Yang Y.; Zhang H.L.; Role of microglia in neurological disorders and their potentials as a therapeutic target. Mol Neurobiol 2017,54(10),7567-7584","journal-title":"Mol Neurobiol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10571-017-0504-2","volume":"38","author":"Kabba J.A.","year":"2018","unstructured":"Kabba J.A.; Xu Y.; Christian H.; Ruan W.; Chenai K.; Xiang Y.; Zhang L.; Saavedra J.M.; Pang T.; Microglia: Housekeeper of the central nervous system. Cell Mol Neurobiol 2018,38(1),53-71","journal-title":"Cell Mol Neurobiol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/nn.4338","volume":"19","author":"Ransohoff R.M.","year":"2016","unstructured":"Ransohoff R.M.; A polarizing question: do M1 and M2 microglia exist? Nat Neurosci 2016,19(8),987-991","journal-title":"Nat Neurosci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nrd3505","volume":"10","author":"Karran E.","year":"2011","unstructured":"Karran E.; Mercken M.; De Strooper B.; The amyloid cascade hypothesis for Alzheimer\u2019s disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 2011,10(9),698-712","journal-title":"Nat Rev Drug Discov"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"8240","DOI":"10.1523\/JNEUROSCI.1808-05.2005","volume":"25","author":"Koenigsknecht-Talboo J.","year":"2005","unstructured":"Koenigsknecht-Talboo J.; Landreth G.E.; Microglial phagocytosis induced by fibrillar beta-amyloid and IgGs are differentially regulated by proinflammatory cytokines. J Neurosci 2005,25(36),8240-8249","journal-title":"J Neurosci"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1523\/JNEUROSCI.18-06-02161.1998","volume":"18","author":"Weldon D.T.","year":"1998","unstructured":"Weldon D.T.; Rogers S.D.; Ghilardi J.R.; Finke M.P.; Cleary J.P.; O\u2019Hare E.; Esler W.P.; Maggio J.E.; Mantyh P.W.; Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo. J Neurosci 1998,18(6),2161-2173","journal-title":"J Neurosci"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3389\/fimmu.2014.00594","volume":"5","author":"Cherry J.D.","year":"2014","unstructured":"Cherry J.D.; Olschowka J.A.; O\u2019Banion M.K.; Are \u201cresting\u201d microglia more \u201cm2\u201d? Front Immunol 2014,5,594","journal-title":"Front Immunol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"11650","DOI":"10.1523\/JNEUROSCI.3024-08.2008","volume":"28","author":"Jimenez S.","year":"2008","unstructured":"Jimenez S.; Baglietto-Vargas D.; Caballero C.; Moreno-Gonzalez I.; Torres M.; Sanchez-Varo R.; Ruano D.; Vizuete M.; Gutierrez A.; Vitorica J.; Inflammatory response in the hippocampus of PS1M146L\/APP751SL mouse model of Alzheimer\u2019s disease: age-dependent switch in the microglial phenotype from alternative to classic. J Neurosci 2008,28(45),11650-11661","journal-title":"J Neurosci"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.neuron.2014.11.020","volume":"85","author":"Chakrabarty P.","year":"2015","unstructured":"Chakrabarty P.; Li A.; Ceballos-Diaz C.; Eddy J.A.; Funk C.C.; Moore B.; DiNunno N.; Rosario A.M.; Cruz P.E.; Verbeeck C.; Sacino A.; Nix S.; Janus C.; Price N.D.; Das P.; Golde T.E.; IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior. Neuron 2015,85(3),519-533","journal-title":"Neuron"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1750-1326-7-36","volume":"7","author":"Chakrabarty P.","year":"2012","unstructured":"Chakrabarty P.; Tianbai L.; Herring A.; Ceballos-Diaz C.; Das P.; Golde T.E.; Hippocampal expression of murine IL-4 results in exacerbation of amyloid deposition. Mol Neurodegener 2012,7,36","journal-title":"Mol Neurodegener"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.neuron.2014.12.068","volume":"85","author":"Guillot-Sestier M.V.","year":"2015","unstructured":"Guillot-Sestier M.V.; Doty K.R.; Gate D.; Rodriguez J.; Leung B.P.; Rezai-Zadeh K.; Town T.; Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology. Neuron 2015,85(3),534-548","journal-title":"Neuron"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/nm1781","volume":"14","author":"Town T.","year":"2008","unstructured":"Town T.; Laouar Y.; Pittenger C.; Mori T.; Szekely C.A.; Tan J.; Duman R.S.; Flavell R.A.; Blocking TGF-beta-Smad2\/3 innate immune signaling mitigates Alzheimer-like pathology. Nat Med 2008,14(6),681-687","journal-title":"Nat Med"},{"key":"ref=32","first-page":"45","volume":"90","author":"DiChiara T.","year":"2017","unstructured":"DiChiara T.; DiNunno N.; Clark J.; Bu R.L.; Cline E.N.; Rollins M.G.; Gong Y.; Brody D.L.; Sligar S.G.; Velasco P.T.; Viola K.L.; Klein W.L.; Alzheimer\u2019s toxic amyloid beta oligomers: unwelcome visitors to the na\/k atpase alpha3 docking station. Yale J Biol Med 2017,90(1),45-61","journal-title":"Yale J Biol Med"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1073\/pnas.0809158106","volume":"106","author":"De Felice F.G.","year":"2009","unstructured":"De Felice F.G.; Vieira M.N.; Bomfim T.R.; Decker H.; Velasco P.T.; Lambert M.P.; Viola K.L.; Zhao W.Q.; Ferreira S.T.; Klein W.L.; Protection of synapses against Alzheimer\u2019s-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. Proc Natl Acad Sci USA 2009,106(6),1971-1976","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1096\/fj.06-7703com","volume":"22","author":"Zhao W.Q.","year":"2008","unstructured":"Zhao W.Q.; De Felice F.G.; Fernandez S.; Chen H.; Lambert M.P.; Quon M.J.; Krafft G.A.; Klein W.L.; Amyloid beta oligomers induce impairment of neuronal insulin receptors. FASEB J 2008,22(1),246-260","journal-title":"FASEB J"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ceca.2011.02.001","volume":"49","author":"Texid\u00f3 L.","year":"2011","unstructured":"Texid\u00f3 L.; Mart\u00edn-Satu\u00e9 M.; Alberdi E.; Solsona C.; Matute C.; Amyloid \u03b2 peptide oligomers directly activate NMDA receptors. Cell Calcium 2011,49(3),184-190","journal-title":"Cell Calcium"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3389\/fncel.2019.00339","volume":"13","author":"Zhang Y.","year":"2019","unstructured":"Zhang Y.; Zhao Y.; Zhang L.; Yu W.; Wang Y.; Chang W.; Cellular prion protein as a receptor of toxic amyloid-\u03b242 oligomers is important for Alzheimer\u2019s disease. Front Cell Neurosci 2019,13,339","journal-title":"Front Cell Neurosci"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.bbadis.2006.10.016","volume":"1772","author":"Copani A.","year":"2007","unstructured":"Copani A.; Caraci F.; Hoozemans J.J.; Calafiore M.; Sortino M.A.; Nicoletti F.; The nature of the cell cycle in neurons: focus on a \u201cnon-canonical\u201d pathway of DNA replication causally related to death. Biochim Biophys Acta 2007,1772(4),409-412","journal-title":"Biochim Biophys Acta"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/jnr.21487","volume":"86","author":"Frasca G.","year":"2008","unstructured":"Frasca G.; Carbonaro V.; Merlo S.; Copani A.; Sortino M.A.; Integrins mediate beta-amyloid-induced cell-cycle activation and neuronal death. J Neurosci Res 2008,86(2),350-355","journal-title":"J Neurosci Res"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"9232","DOI":"10.1523\/JNEUROSCI.3347-04.2004","volume":"24","author":"Herrup K.","year":"2004","unstructured":"Herrup K.; Neve R.; Ackerman S.L.; Copani A.; Divide and die: cell cycle events as triggers of nerve cell death. J Neurosci 2004,24(42),9232-9239","journal-title":"J Neurosci"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1021\/acs.jnatprod.5b00621","volume":"78","author":"Merlo S.","year":"2015","unstructured":"Merlo S.; Basile L.; Giuffrida M.L.; Sortino M.A.; Guccione S.; Copani A.; Identification of 5-Methoxyflavone as a novel dna polymerase-beta inhibitor and neuroprotective agent against beta-amyloid toxicity. J Nat Prod 2015,78(11),2704-2711","journal-title":"J Nat Prod"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1096\/fj.02-0422fje","volume":"16","author":"Copani A.","year":"2002","unstructured":"Copani A.; Sortino M.A.; Caricasole A.; Chiechio S.; Chisari M.; Battaglia G.; Giuffrida-Stella A.M.; Vancheri C.; Nicoletti F.; Erratic expression of DNA polymerases by beta-amyloid causes neuronal death. FASEB J 2002,16(14),2006-2008","journal-title":"FASEB J"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bpc.2013.07.010","volume":"182","author":"Canale C.","year":"2013","unstructured":"Canale C.; Seghezza S.; Vilasi S.; Carrotta R.; Bulone D.; Diaspro A.; San Biagio P.L.; Dante S.; Different effects of Alzheimer\u2019s peptide A\u03b2(1-40) oligomers and fibrils on supported lipid membranes. Biophys Chem 2013,182,23-29","journal-title":"Biophys Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/S0196-9781(02)00067-0","volume":"23","author":"Kagan B.L.","year":"2002","unstructured":"Kagan B.L.; Hirakura Y.; Azimov R.; Azimova R.; Lin M.C.; The channel hypothesis of Alzheimer\u2019s disease: current status. Peptides 2002,23(7),1311-1315","journal-title":"Peptides"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1074\/jbc.M116.762526","volume":"292","author":"Bode D.C.","year":"2017","unstructured":"Bode D.C.; Baker M.D.; Viles J.H.; Ion channel formation by amyloid-\u03b242 oligomers but not amyloid-\u03b240 in cellular membranes. J Biol Chem 2017,292(4),1404-1413","journal-title":"J Biol Chem"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3109\/03602532.2014.882354","volume":"46","author":"Drolle E.","year":"2014","unstructured":"Drolle E.; Hane F.; Lee B.; Leonenko Z.; Atomic force microscopy to study molecular mechanisms of amyloid fibril formation and toxicity in Alzheimer\u2019s disease. Drug Metab Rev 2014,46(2),207-223","journal-title":"Drug Metab Rev"},{"key":"ref=46","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/127984","volume":"2011","author":"Mohamed A.","year":"2011","unstructured":"Mohamed A.; Posse de Chaves E.; A\u03b2 internalization by neurons and glia. Int J Alzheimers Dis 2011,2011","journal-title":"Int J Alzheimers Dis"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","volume":"14","author":"Cheignon C.","year":"2018","unstructured":"Cheignon C.; Tomas M.; Bonnefont-Rousselot D.; Faller P.; Hureau C.; Collin F.; Oxidative stress and the amyloid beta peptide in Alzheimer\u2019s disease. Redox Biol 2018,14,450-464","journal-title":"Redox Biol"},{"key":"ref=48","doi-asserted-by":"publisher","DOI":"10.3390\/cells8010064","volume":"8","author":"Caruso G.","year":"2019","unstructured":"Caruso G.; Fresta C.G.; Musso N.; Giambirtone M.; Grasso M.; Spampinato S.F.; Merlo S.; Drago F.; Lazzarino G.; Sortino M.A.; Lunte S.M.; Caraci F.; Carnosine prevents a\u03b2-induced oxidative stress and inflammation in microglial cells: a key role of TGF-\u03b21. Cells 2019,8(1)","journal-title":"Cells"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.2174\/1381612825666191209115431","volume":"25","author":"Caruso G.","year":"2019","unstructured":"Caruso G.; Spampinato S.F.; Cardaci V.; Caraci F.; Sortino M.A.; Merlo S.; beta-amyloid and oxidative stress: perspectives in drug development. Curr Pharm Des 2019,25(45),4771-4781","journal-title":"Curr Pharm Des"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"11590","DOI":"10.1074\/jbc.M607483200","volume":"282","author":"De Felice F.G.","year":"2007","unstructured":"De Felice F.G.; Velasco P.T.; Lambert M.P.; Viola K.; Fernandez S.J.; Ferreira S.T.; Klein W.L.; Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem 2007,282(15),11590-11601","journal-title":"J Biol Chem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.expneurol.2009.03.042","volume":"218","author":"Reddy P.H.","year":"2009","unstructured":"Reddy P.H.; Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer\u2019s disease. Exp Neurol 2009,218(2),286-292","journal-title":"Exp Neurol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1523\/JNEUROSCI.12-02-00376.1992","volume":"12","author":"Mattson M.P.","year":"1992","unstructured":"Mattson M.P.; Cheng B.; Davis D.; Bryant K.; Lieberburg I.; Rydel R.E.; beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 1992,12(2),376-389","journal-title":"J Neurosci"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1742-2094-11-48","volume":"11","author":"Doens D.","year":"2014","unstructured":"Doens D.; Fern\u00e1ndez P.L.; Microglia receptors and their implications in the response to amyloid \u03b2 for Alzheimer\u2019s disease pathogenesis. J Neuroinflammation 2014,11,48","journal-title":"J Neuroinflammation"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12974-019-1453-0","volume":"16","author":"Dionisio-Santos D.A.","year":"2019","unstructured":"Dionisio-Santos D.A.; Olschowka J.A.; O\u2019Banion M.K.; Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer\u2019s disease. J Neuroinflammation 2019,16(1),74","journal-title":"J Neuroinflammation"},{"key":"ref=55","author":"Gabande-Rodriguez E.","year":"2019","unstructured":"Gabande-Rodriguez E.; Keane L.; Capasso M.; Microglial phagocytosis in aging and Alzheimer\u2019s disease. J Neurosci Res 2019","journal-title":"J Neurosci Res"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3389\/fnins.2017.00680","volume":"11","author":"Clayton K.A.","year":"2017","unstructured":"Clayton K.A.; Van Enoo A.A.; Ikezu T.; Alzheimer\u2019s disease: the role of microglia in brain homeostasis and proteopathy. Front Neurosci 2017,11,680","journal-title":"Front Neurosci"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.molmed.2009.12.001","volume":"16","author":"Yanamadala V.","year":"2010","unstructured":"Yanamadala V.; Friedlander R.M.; Complement in neuroprotection and neurodegeneration. Trends Mol Med 2010,16(2),69-76","journal-title":"Trends Mol Med"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.jaci.2009.10.054","volume":"125","author":"van der Kleij H.","year":"2010","unstructured":"van der Kleij H.; Charles N.; Karimi K.; Mao Y.K.; Foster J.; Janssen L.; Chang Yang P.; Kunze W.; Rivera J.; Bienenstock J.; Evidence for neuronal expression of functional Fc (epsilon and gamma) receptors. J Allergy Clin Immunol 2010,125(3),757-760","journal-title":"J Allergy Clin Immunol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1007\/s11064-010-0301-5","volume":"35","author":"Cattaneo F.","year":"2010","unstructured":"Cattaneo F.; Guerra G.; Ammendola R.; Expression and signaling of formyl-peptide receptors in the brain. Neurochem Res 2010,35(12),2018-2026","journal-title":"Neurochem Res"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/glia.10148","volume":"40","author":"Husemann J.","year":"2002","unstructured":"Husemann J.; Loike J.D.; Anankov R.; Febbraio M.; Silverstein S.C.; Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system. Glia 2002,40(2),195-205","journal-title":"Glia"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.tins.2011.02.005","volume":"34","author":"Okun E.","year":"2011","unstructured":"Okun E.; Griffioen K.J.; Mattson M.P.; Toll-like receptor signaling in neural plasticity and disease. Trends Neurosci 2011,34(5),269-281","journal-title":"Trends Neurosci"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/382685a0","volume":"382","author":"Yan S.D.","year":"1996","unstructured":"Yan S.D.; Chen X.; Fu J.; Chen M.; Zhu H.; Roher A.; Slattery T.; Zhao L.; Nagashima M.; Morser J.; Migheli A.; Nawroth P.; Stern D.; Schmidt A.M.; RAGE and amyloid-beta peptide neurotoxicity in Alzheimer\u2019s disease. Nature 1996,382(6593),685-691","journal-title":"Nature"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1254\/jphs.11R10FM","volume":"118","author":"Takata K.","year":"2012","unstructured":"Takata K.; Kitamura Y.; Molecular approaches to the treatment, prophylaxis, and diagnosis of Alzheimer\u2019s disease: tangle formation, amyloid-\u03b2, and microglia in Alzheimer\u2019s disease. J Pharmacol Sci 2012,118(3),331-337","journal-title":"J Pharmacol Sci"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature00858","volume":"418","author":"Scaffidi P.","year":"2002","unstructured":"Scaffidi P.; Misteli T.; Bianchi M.E.; Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002,418(6894),191-195","journal-title":"Nature"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.2174\/1389450120666190618125100","volume":"20","author":"Vijayakumar E.C.","year":"2019","unstructured":"Vijayakumar E.C.; Bhatt L.K.; Prabhavalkar K.S.; High mobility group box-1 (hmgb1): a potential target in therapeutics. Curr Drug Targets 2019,20(14),1474-1485","journal-title":"Curr Drug Targets"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0006-291X(03)00024-X","volume":"301","author":"Takata K.","year":"2003","unstructured":"Takata K.; Kitamura Y.; Kakimura J.; Shibagaki K.; Tsuchiya D.; Taniguchi T.; Smith M.A.; Perry G.; Shimohama S.; Role of high mobility group protein-1 (HMG1) in amyloid-beta homeostasis. Biochem Biophys Res Commun 2003,301(3),699-703","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=67","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/685739","volume":"2012","author":"Takata K.","year":"2012","unstructured":"Takata K.; Takada T.; Ito A.; Asai M.; Tawa M.; Saito Y.; Ashihara E.; Tomimoto H.; Kitamura Y.; Shimohama S.; Microglial amyloid-\u03b21-40 phagocytosis dysfunction is caused by high-mobility group box protein-1: implications for the pathological progression of Alzheimer\u2019s disease. Int J Alzheimers Dis 2012,2012","journal-title":"Int J Alzheimers Dis"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3389\/fphar.2015.00126","volume":"6","author":"Sinagra T.","year":"2015","unstructured":"Sinagra T.; Merlo S.; Spampinato S.F.; Pasquale R.D.; Sortino M.A.; High mobility group box 1 contributes to wound healing induced by inhibition of dipeptidylpeptidase 4 in cultured keratinocytes. Front Pharmacol 2015,6,126","journal-title":"Front Pharmacol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1038\/sj.jid.5701212","volume":"128","author":"Straino S.","year":"2008","unstructured":"Straino S.; Di Carlo A.; Mangoni A.; De Mori R.; Guerra L.; Maurelli R.; Panacchia L.; Di Giacomo F.; Palumbo R.; Di Campli C.; Uccioli L.; Biglioli P.; Bianchi M.E.; Capogrossi M.C.; Germani A.; High-mobility group box 1 protein in human and murine skin: involvement in wound healing. J Invest Dermatol 2008,128(6),1545-1553","journal-title":"J Invest Dermatol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.2174\/1871527315666160803153459","volume":"16","author":"Bortolotto V.","year":"2017","unstructured":"Bortolotto V.; Grilli M.; Every cloud has a silver lining: proneurogenic effects of a\u03b2 oligomers and hmgb-1 via activation of the rage-nf-\u03bab axis. CNS Neurol Disord Drug Targets 2017,16(10),1066-1079","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13024-015-0048-1","volume":"10","author":"Malik M.","year":"2015","unstructured":"Malik M.; Parikh I.; Vasquez J.B.; Smith C.; Tai L.; Bu G.; LaDu M.J.; Fardo D.W.; Rebeck G.W.; Estus S.; Genetics ignite focus on microglial inflammation in Alzheimer\u2019s disease. Mol Neurodegener 2015,10,52","journal-title":"Mol Neurodegener"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neuron.2018.01.031","volume":"97","author":"Zhao Y.","year":"2018","unstructured":"Zhao Y.; Wu X.; Li X.; Jiang L.L.; Gui X.; Liu Y.; Sun Y.; Zhu B.; Pina-Crespo J.C.; Zhang M.; Zhang N.; Chen X.; Bu G.; An Z.; Huang T.Y.; Xu H.; trem2 is a receptor for betaamyloid\n that mediates microglial function. Neuron e10272018,97(5),1023-1031","journal-title":"Neuron"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13024-018-0247-7","volume":"13","author":"Zhong L.","year":"2018","unstructured":"Zhong L.; Wang Z.; Wang D.; Wang Z.; Martens Y.A.; Wu L.; Xu Y.; Wang K.; Li J.; Huang R.; Can D.; Xu H.; Bu G.; Chen X.F.; Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2). Mol Neurodegener 2018,13(1),15","journal-title":"Mol Neurodegener"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"5838","DOI":"10.1093\/hmg\/ddu277","volume":"23","author":"Jin S.C.","year":"2014","unstructured":"Jin S.C.; Benitez B.A.; Karch C.M.; Cooper B.; Skorupa T.; Carrell D.; Norton J.B.; Hsu S.; Harari O.; Cai Y.; Bertelsen S.; Goate A.M.; Cruchaga C.; Coding variants in TREM2 increase risk for Alzheimer\u2019s disease. Hum Mol Genet 2014,23(21),5838-5846","journal-title":"Hum Mol Genet"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"Jonsson T.","year":"2013","unstructured":"Jonsson T.; Stefansson H.; Steinberg S.; Jonsdottir I.; Jonsson P.V.; Snaedal J.; Bjornsson S.; Huttenlocher J.; Levey A.I.; Lah J.J.; Rujescu D.; Hampel H.; Giegling I.; Andreassen O.A.; Engedal K.; Ulstein I.; Djurovic S.; Ibrahim-Verbaas C.; Hofman A.; Ikram M.A.; van Duijn C.M.; Thorsteinsdottir U.; Kong A.; Stefansson K.; Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med 2013,368(2),107-116","journal-title":"N Engl J Med"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.molmed.2017.03.008","volume":"23","author":"Yeh F.L.","year":"2017","unstructured":"Yeh F.L.; Hansen D.V.; Sheng M.; TREM2, Microglia, and Neurodegenerative Diseases. Trends Mol Med 2017,23(6),512-533","journal-title":"Trends Mol Med"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.neuron.2018.02.002","volume":"97","author":"Lee C.Y.D.","year":"2018","unstructured":"Lee C.Y.D.; Daggett A.; Gu X.; Jiang L.L.; Langfelder P.; Li X.; Wang N.; Zhao Y.; Park C.S.; Cooper Y.; Ferando I.; Mody I.; Coppola G.; Xu H.; Yang X.W.; elevated trem2 gene dosage\n reprograms microglia responsivity and ameliorates pathological\n phenotypes in alzheimer's disease models. Neuron  e10352018,97(5),1032-1048","journal-title":"Neuron"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1084\/jem.20151948","volume":"213","author":"Wang Y.","year":"2016","unstructured":"Wang Y.; Ulland T.K.; Ulrich J.D.; Song W.; Tzaferis J.A.; Hole J.T.; Yuan P.; Mahan T.E.; Shi Y.; Gilfillan S.; Cella M.; Grutzendler J.; DeMattos R.B.; Cirrito J.R.; Holtzman D.M.; Colonna M.; TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J Exp Med 2016,213(5),667-675","journal-title":"J Exp Med"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.neuron.2016.05.003","volume":"90","author":"Yuan P.","year":"2016","unstructured":"Yuan P.; Condello C.; Keene C.D.; Wang Y.; Bird T.D.; Paul S.M.; Luo W.; Colonna M.; Baddeley D.; Grutzendler J.; TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy. Neuron 2016,90(4),724-739","journal-title":"Neuron"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1084\/jem.20142322","volume":"212","author":"Jay T.R.","year":"2015","unstructured":"Jay T.R.; Miller C.M.; Cheng P.J.; Graham L.C.; Bemiller S.; Broihier M.L.; Xu G.; Margevicius D.; Karlo J.C.; Sousa G.L.; Cotleur A.C.; Butovsky O.; Bekris L.; Staugaitis S.M.; Leverenz J.B.; Pimplikar S.W.; Landreth G.E.; Howell G.R.; Ransohoff R.M.; Lamb B.T.; TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer\u2019s disease mouse models. J Exp Med 2015,212(3),287-295","journal-title":"J Exp Med"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1056\/NEJMcibr1503954","volume":"372","author":"Tanzi R.E.","year":"2015","unstructured":"Tanzi R.E.; TREM2 and Risk of Alzheimer\u2019s Disease--Friend or Foe? N Engl J Med 2015,372(26),2564-2565","journal-title":"N Engl J Med"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.neuron.2018.02.018","volume":"97","author":"Udeochu J.","year":"2018","unstructured":"Udeochu J.; Sayed F.A.; Gan L.; TREM2 and Amyloid Beta: A Love-Hate Relationship. Neuron 2018,97(5),991-993","journal-title":"Neuron"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1523\/JNEUROSCI.2110-16.2016","volume":"37","author":"Jay T.R.","year":"2017","unstructured":"Jay T.R.; Hirsch A.M.; Broihier M.L.; Miller C.M.; Neilson L.E.; Ransohoff R.M.; Lamb B.T.; Landreth G.E.; Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer\u2019s Disease. J Neurosci 2017,37(3),637-647","journal-title":"J Neurosci"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1523\/JNEUROSCI.2459-16.2017","volume":"37","author":"Zheng H.","year":"2017","unstructured":"Zheng H.; Jia L.; Liu C.C.; Rong Z.; Zhong L.; Yang L.; Chen X.F.; Fryer J.D.; Wang X.; Zhang Y.W.; Xu H.; Bu G.; TREM2 Promotes Microglial Survival by Activating Wnt\/\u03b2-Catenin Pathway. J Neurosci 2017,37(7),1772-1784","journal-title":"J Neurosci"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1084\/jem.20160844","volume":"214","author":"Zhong L.","year":"2017","unstructured":"Zhong L.; Chen X.F.; Wang T.; Wang Z.; Liao C.; Wang Z.; Huang R.; Wang D.; Li X.; Wu L.; Jia L.; Zheng H.; Painter M.; Atagi Y.; Liu C.C.; Zhang Y.W.; Fryer J.D.; Xu H.; Bu G.; Soluble TREM2 induces inflammatory responses and enhances microglial survival. J Exp Med 2017,214(3),597-607","journal-title":"J Exp Med"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-018-0301-5","volume":"14","author":"Su\u00e1rez-Calvet M.","year":"2019","unstructured":"Su\u00e1rez-Calvet M.; Morenas-Rodr\u00edguez E.; Kleinberger G.; Schlepckow K.; Araque Caballero M.A.; Franzmeier N.; Capell A.; Fellerer K.; Nuscher B.; Eren E.; Levin J.; Deming Y.; Piccio L.; Karch C.M.; Cruchaga C.; Shaw L.M.; Trojanowski J.Q.; Weiner M.; Ewers M.; Haass C.; Early increase of CSF sTREM2 in Alzheimer\u2019s disease is associated with tau related-neurodegeneration but not with amyloid-\u03b2 pathology. Mol Neurodegener Alzheimer\u2019s Disease Neuroimaging Initiative2019,14(1),1","journal-title":"Mol Neurodegener"},{"key":"ref=87","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aav6221","volume":"11","author":"Ewers M.","year":"2019","unstructured":"Ewers M.; Franzmeier N.; Su\u00e1rez-Calvet M.; Morenas-Rodriguez E.; Caballero M.A.A.; Kleinberger G.; Piccio L.; Cruchaga C.; Deming Y.; Dichgans M.; Trojanowski J.Q.; Shaw L.M.; Weiner M.W.; Haass C.; Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer\u2019s disease. Sci Transl Med Alzheimer\u2019s Disease Neuroimaging Initiative2019,11(507)","journal-title":"Sci Transl Med"},{"key":"ref=88","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau2291","volume":"11","author":"Deming Y.","year":"2019","unstructured":"Deming Y.; Filipello F.; Cignarella F.; Cantoni C.; Hsu S.; Mikesell R.; Li Z.; Del-Aguila J.L.; Dube U.; Farias F.G.; Bradley J.; Budde J.; Ibanez L.; Fernandez M.V.; Blennow K.; Zetterberg H.; Heslegrave A.; Johansson P.M.; Svensson J.; Nellg\u00e5rd B.; Lleo A.; Alcolea D.; Clarimon J.; Rami L.; Molinuevo J.L.; Su\u00e1rez-Calvet M.; Morenas-Rodr\u00edguez E.; Kleinberger G.; Ewers M.; Harari O.; Haass C.; Brett T.J.; Benitez B.A.; Karch C.M.; Piccio L.; Cruchaga C.; The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer\u2019s disease risk. Sci Transl Med 2019,11(505)","journal-title":"Sci Transl Med"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3389\/fncel.2019.00457","volume":"13","author":"Yao H.","year":"2019","unstructured":"Yao H.; Coppola K.; Schweig J.E.; Crawford F.; Mullan M.; Paris D.; Distinct signaling pathways regulate TREM2 phagocytic and NF\u03baB antagonistic activities. Front Cell Neurosci 2019,13,457","journal-title":"Front Cell Neurosci"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nri2056","volume":"7","author":"Crocker P.R.","year":"2007","unstructured":"Crocker P.R.; Paulson J.C.; Varki A.; Siglecs and their roles in the immune system. Nat Rev Immunol 2007,7(4),255-266","journal-title":"Nat Rev Immunol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/eji.200425273","volume":"35","author":"Lajaunias F.","year":"2005","unstructured":"Lajaunias F.; Dayer J.M.; Chizzolini C.; Constitutive repressor activity of CD33 on human monocytes requires sialic acid recognition and phosphoinositide 3-kinase-mediated intracellular signaling. Eur J Immunol 2005,35(1),243-251","journal-title":"Eur J Immunol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/ng.801","volume":"43","author":"Naj A.C.","year":"2011","unstructured":"Naj A.C.; Jun G.; Beecham G.W.; Wang L.S.; Vardarajan B.N.; Buros J.; Gallins P.J.; Buxbaum J.D.; Jarvik G.P.; Crane P.K.; Larson E.B.; Bird T.D.; Boeve B.F.; Graff-Radford N.R.; De Jager P.L.; Evans D.; Schneider J.A.; Carrasquillo M.M.; Ertekin-Taner N.; Younkin S.G.; Cruchaga C.; Kauwe J.S.; Nowotny P.; Kramer P.; Hardy J.; Huentelman M.J.; Myers A.J.; Barmada M.M.; Demirci F.Y.; Baldwin C.T.; Green R.C.; Rogaeva E.; St George-Hyslop P.; Arnold S.E.; Barber R.; Beach T.; Bigio E.H.; Bowen J.D.; Boxer A.; Burke J.R.; Cairns N.J.; Carlson C.S.; Carney R.M.; Carroll S.L.; Chui H.C.; Clark D.G.; Corneveaux J.; Cotman C.W.; Cummings J.L.; DeCarli C.; DeKosky S.T.; Diaz-Arrastia R.; Dick M.; Dickson D.W.; Ellis W.G.; Faber K.M.; Fallon K.B.; Farlow M.R.; Ferris S.; Frosch M.P.; Galasko D.R.; Ganguli M.; Gearing M.; Geschwind D.H.; Ghetti B.; Gilbert J.R.; Gilman S.; Giordani B.; Glass J.D.; Growdon J.H.; Hamilton R.L.; Harrell L.E.; Head E.; Honig L.S.; Hulette C.M.; Hyman B.T.; Jicha G.A.; Jin L.W.; Johnson N.; Karlawish J.; Karydas A.; Kaye J.A.; Kim R.; Koo E.H.; Kowall N.W.; Lah J.J.; Levey A.I.; Lieberman A.P.; Lopez O.L.; Mack W.J.; Marson D.C.; Martiniuk F.; Mash D.C.; Masliah E.; McCormick W.C.; McCurry S.M.; McDavid A.N.; McKee A.C.; Mesulam M.; Miller B.L.; Miller C.A.; Miller J.W.; Parisi J.E.; Perl D.P.; Peskind E.; Petersen R.C.; Poon W.W.; Quinn J.F.; Rajbhandary R.A.; Raskind M.; Reisberg B.; Ringman J.M.; Roberson E.D.; Rosenberg R.N.; Sano M.; Schneider L.S.; Seeley W.; Shelanski M.L.; Slifer M.A.; Smith C.D.; Sonnen J.A.; Spina S.; Stern R.A.; Tanzi R.E.; Trojanowski J.Q.; Troncoso J.C.; Van Deerlin V.M.; Vinters H.V.; Vonsattel J.P.; Weintraub S.; Welsh-Bohmer K.A.; Williamson J.; Woltjer R.L.; Cantwell L.B.; Dombroski B.A.; Beekly D.; Lunetta K.L.; Martin E.R.; Kamboh M.I.; Saykin A.J.; Reiman E.M.; Bennett D.A.; Morris J.C.; Montine T.J.; Goate A.M.; Blacker D.; Tsuang D.W.; Hakonarson H.; Kukull W.A.; Foroud T.M.; Haines J.L.; Mayeux R.; Pericak-Vance M.A.; Farrer L.A.; Schellenberg G.D.; Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer\u2019s disease. Nat Genet 2011,43(5),436-441","journal-title":"Nat Genet"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1159\/000492596","volume":"65","author":"Zhao L.","year":"2019","unstructured":"Zhao L.; CD33 in Alzheimer\u2019s Disease - biology, pathogenesis, and therapeutics: A mini-review. Gerontology 2019,65(4),323-331","journal-title":"Gerontology"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00401-019-02000-4","volume":"138","author":"Estus S.","year":"2019","unstructured":"Estus S.; Shaw B.C.; Devanney N.; Katsumata Y.; Press E.E.; Fardo D.W.; Evaluation of CD33 as a genetic risk factor for Alzheimer\u2019s disease. Acta Neuropathol 2019,138(2),187-199","journal-title":"Acta Neuropathol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.neuron.2019.06.010","volume":"103","author":"Griciuc A.","year":"2019","unstructured":"Griciuc A.; Patel S.; Federico A.N.; Choi S.H.; Innes B.J.; Oram M.K.; Cereghetti G.; McGinty D.; Anselmo A.; Sadreyev R.I.; Hickman S.E.; El Khoury J.; Colonna M.; Tanzi R.E.; trem2\n acts downstream of cd33 in modulating microglial pathology in\n alzheimer's disease., Neuron  e827.2019,103(5),820-835","journal-title":"Neuron"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","volume":"78","author":"Griciuc A.","year":"2013","unstructured":"Griciuc A.; Serrano-Pozo A.; Parrado A.R.; Lesinski A.N.; Asselin C.N.; Mullin K.; Hooli B.; Choi S.H.; Hyman B.T.; Tanzi R.E.; Alzheimer\u2019s disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron 2013,78(4),631-643","journal-title":"Neuron"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1126\/science.1202529","volume":"333","author":"Paolicelli R.C.","year":"2011","unstructured":"Paolicelli R.C.; Bolasco G.; Pagani F.; Maggi L.; Scianni M.; Panzanelli P.; Giustetto M.; Ferreira T.A.; Guiducci E.; Dumas L.; Ragozzino D.; Gross C.T.; Synaptic pruning by microglia is necessary for normal brain development. Science 2011,333(6048),1456-1458","journal-title":"Science"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/brain\/awn109","volume":"132","author":"Neumann H.","year":"2009","unstructured":"Neumann H.; Kotter M.R.; Franklin R.J.; Debris clearance by microglia: an essential link between degeneration and regeneration. Brain 2009,132(Pt 2),288-295","journal-title":"Brain"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/s41593-018-0192-3","volume":"21","author":"Ayata P.","year":"2018","unstructured":"Ayata P.; Badimon A.; Strasburger H.J.; Duff M.K.; Montgomery S.E.; Loh Y.E.; Ebert A.; Pimenova A.A.; Ramirez B.R.; Chan A.T.; Sullivan J.M.; Purushothaman I.; Scarpa J.R.; Goate A.M.; Busslinger M.; Shen L.; Losic B.; Schaefer A.; Epigenetic regulation of brain region-specific microglia clearance activity. Nat Neurosci 2018,21(8),1049-1060","journal-title":"Nat Neurosci"},{"key":"ref=100","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.immuni.2018.02.016","volume":"48","author":"Datta M.","year":"2018","unstructured":"Datta M.; Staszewski O.; Raschi E.; Frosch M.; Hagemeyer N.; Tay T.L.; Blank T.; Kreutzfeldt M.; Merkler D.; Ziegler-Waldkirch S.; Matthias P.; Meyer-Luehmann M.; Prinz M.; Histone\n deacetylases 1 and 2 regulate microglia function during development,\n homeostasis, and neurodegeneration in a contextdependent\n manner. immunity  e516.2018,48(3),514-529","journal-title":"immunity"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/acel.12642","volume":"16","author":"Zhu X.","year":"2017","unstructured":"Zhu X.; Wang S.; Yu L.; Jin J.; Ye X.; Liu Y.; Xu Y.; HDAC3 negatively regulates spatial memory in a mouse model of Alzheimer\u2019s disease. Aging Cell 2017,16(5),1073-1082","journal-title":"Aging Cell"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"E11148","DOI":"10.1073\/pnas.1805436115","volume":"115","author":"Janczura K.J.","year":"2018","unstructured":"Janczura K.J.; Volmar C.H.; Sartor G.C.; Rao S.J.; Ricciardi N.R.; Lambert G.; Brothers S.P.; Wahlestedt C.; Inhibition of HDAC3 reverses Alzheimer\u2019s disease-related pathologies in vitro and in the 3xTg-AD mouse model. Proc Natl Acad Sci USA 2018,115(47),E11148-E11157","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s13238-016-0269-2","volume":"7","author":"Bao J.","year":"2016","unstructured":"Bao J.; Zheng L.; Zhang Q.; Li X.; Zhang X.; Li Z.; Bai X.; Zhang Z.; Huo W.; Zhao X.; Shang S.; Wang Q.; Zhang C.; Ji J.; Deacetylation of TFEB promotes fibrillar A\u03b2 degradation by upregulating lysosomal biogenesis in microglia. Protein Cell 2016,7(6),417-433","journal-title":"Protein Cell"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jinorgbio.2013.05.010","volume":"128","author":"Alexandrov P.N.","year":"2013","unstructured":"Alexandrov P.N.; Zhao Y.; Jones B.M.; Bhattacharjee S.; Lukiw W.J.; Expression of the phagocytosis-essential protein TREM2 is down-regulated by an aluminum-induced miRNA-34a in a murine microglial cell line. J Inorg Biochem 2013,128,267-269","journal-title":"J Inorg Biochem"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/WNR.0b013e32835fb6b0","volume":"24","author":"Zhao Y.","year":"2013","unstructured":"Zhao Y.; Bhattacharjee S.; Jones B.M.; Dua P.; Alexandrov P.N.; Hill J.M.; Lukiw W.J.; Regulation of TREM2 expression by an NF-\u043aB-sensitive miRNA-34a. Neuroreport 2013,24(6),318-323","journal-title":"Neuroreport"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13578-019-0354-3","volume":"9","author":"Madadi S.","year":"2019","unstructured":"Madadi S.; Schwarzenbach H.; Saidijam M.; Mahjub R.; Soleimani M.; Potential microRNA-related targets in clearance pathways of amyloid-\u03b2: novel therapeutic approach for the treatment of Alzheimer\u2019s disease. Cell Biosci 2019,9,91","journal-title":"Cell Biosci"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.trci.2019.05.008","volume":"5","author":"Cummings J.","year":"2019","unstructured":"Cummings J.; Lee G.; Ritter A.; Sabbagh M.; Zhong K.; Alzheimer\u2019s disease drug development pipeline: 2019. Alzheimers Dement (N Y) 2019,5,272-293","journal-title":"Alzheimers Dement (N Y)"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41582-018-0072-1","volume":"14","author":"Ulland T.K.","year":"2018","unstructured":"Ulland T.K.; Colonna M.; TREM2 - a key player in microglial biology and Alzheimer disease. Nat Rev Neurol 2018,14(11),667-675","journal-title":"Nat Rev Neurol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12035-010-8106-8","volume":"41","author":"Lue L.F.","year":"2010","unstructured":"Lue L.F.; Kuo Y.M.; Beach T.; Walker D.G.; Microglia activation and anti-inflammatory regulation in Alzheimer\u2019s disease. Mol Neurobiol 2010,41(2-3),115-128","journal-title":"Mol Neurobiol"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.cell.2013.11.030","volume":"155","author":"Parkhurst C.N.","year":"2013","unstructured":"Parkhurst C.N.; Yang G.; Ninan I.; Savas J.N.; Yates J.R.; Lafaille J.J.; Hempstead B.L.; Littman D.R.; Gan W.B.; Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell 2013,155(7),1596-1609","journal-title":"Cell"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"Keren-Shaul H.","year":"2017","unstructured":"Keren-Shaul H.; Spinrad A.; Weiner A.; Matcovitch-Natan O.; Dvir-Szternfeld R.; Ulland T.K.; David E.; Baruch K.; Lara-Astaiso D.; Toth B.; Itzkovitz S.; Colonna M.; Schwartz M.; Amit I.; A Unique microglia type associated with restricting development of Alzheimer's disease. Cell e1217.2017,169(7),1276-1290","journal-title":"Cell"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","volume":"170","author":"Ulland T.K.","year":"2017","unstructured":"Ulland T.K.; Song W.M.; Huang S.C.; Ulrich J.D.; Sergushichev A.; Beatty W.L.; Loboda A.A.; Zhou Y.; Cairns N.J.; Kambal A.; Loginicheva E.; Gilfillan S.; Cella M.; Virgin H.W.; Unanue E.R.; Wang Y.; Artyomov M.N.; Holtzman D.M.; Colonna M.; TREM2 maintains microglial metabolic fitness in alzheimer's\n disease. Cell e613.2017,170(4),649-663","journal-title":"Cell"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"Hong S.","year":"2016","unstructured":"Hong S.; Beja-Glasser V.F.; Nfonoyim B.M.; Frouin A.; Li S.; Ramakrishnan S.; Merry K.M.; Shi Q.; Rosenthal A.; Barres B.A.; Lemere C.A.; Selkoe D.J.; Stevens B.; Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 2016,352(6286),712-716","journal-title":"Science"}],"container-title":["Current Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/178882","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T10:48:23Z","timestamp":1594205303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/178882\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,20]]},"references-count":113,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5,20]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570159x18666200131105418","relation":{},"ISSN":["1570-159X"],"issn-type":[{"value":"1570-159X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,20]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-12-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}